Results
|
|
63201.
|
|
|
|
63202.
|
|
|
|
63203.
|
|
|
|
63204.
|
|
|
|
63205.
|
|
|
|
63206.
|
|
|
|
63207.
|
|
|
|
63208.
|
|
|
|
63209.
|
|
|
|
63210.
|
|
|
|
63211.
|
|
|
|
63212.
|
|
|
|
63213.
|
|
|
|
63214.
|
|
|
|
63215.
|
|
|
|
63216.
|
|
|
|
63217.
|
|
|
|
63218.
|
A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis. [electronic resource] by
- Foran, James
- Ravandi, Farhad
- Wierda, William
- Garcia-Manero, Guillermo
- Verstovsek, Srdan
- Kadia, Tapan
- Burger, Jan
- Yule, Murray
- Langford, Gillian
- Lyons, John
- Ayrton, John
- Lock, Victoria
- Borthakur, Gautham
- Cortes, Jorge
- Kantarjian, Hagop
Producer: 20150106
In:
Clinical lymphoma, myeloma & leukemia vol. 14
Availability: No items available.
|
|
|
63219.
|
|
|
|
63220.
|
|